Bank of New York Mellon Corp - PLIANT THERAPEUTICS INC ownership

PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 78 filers reported holding PLIANT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of PLIANT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,471,885
+3.8%
200,224
+8.4%
0.00%0.0%
Q2 2023$3,345,785
+395.4%
184,646
+627.3%
0.00%
Q1 2023$675,321
+138.0%
25,388
+73.0%
0.00%
Q4 2022$283,707
-61.3%
14,677
-58.2%
0.00%
Q3 2022$733,000
+762.4%
35,114
+232.2%
0.00%
Q2 2022$85,000
-83.4%
10,570
-85.6%
0.00%
Q1 2022$513,000
-48.3%
73,299
-0.2%
0.00%
Q4 2021$992,000
-21.1%
73,462
-1.4%
0.00%
Q3 2021$1,257,000
-27.2%
74,470
+25.6%
0.00%
Q2 2021$1,727,000
-75.0%
59,290
-66.3%
0.00%
-100.0%
Q1 2021$6,920,000
+222.5%
175,948
+86.3%
0.00%
Q4 2020$2,146,000
+9.9%
94,451
+9.6%
0.00%
Q3 2020$1,953,000
+198.6%
86,190
+327.9%
0.00%
Q2 2020$654,00020,1420.00%
Other shareholders
PLIANT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TRV GP III, LLC 339,160$5,881,034100.00%
CHI Advisors LLC 3,014,199$52,266,21120.72%
TRV GP IV, LLC 2,132,867$36,983,91413.93%
GREAT POINT PARTNERS LLC 1,755,184$30,434,8915.54%
First Light Asset Management, LLC 2,933,260$50,862,7284.83%
Deep Track Capital, LP 5,500,000$95,370,0003.68%
Casdin Capital, LLC 1,577,108$27,347,0533.03%
Fernwood Investment Management, LLC 379,702$6,584,0332.37%
Redmile Group, LLC 2,678,099$46,438,2372.21%
SILVERARC CAPITAL MANAGEMENT, LLC 250,409$4,342,0921.32%
View complete list of PLIANT THERAPEUTICS INC shareholders